MS, P., J, L., S, S., PC, R., B, R., VC, L., . . . KSM, S. (2025). Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models. Journal for immunotherapy of cancer, 13(8), . https://doi.org/10.1136/jitc-2025-012011
Chicago Style (17th ed.) CitationMS, Phadke, Li J, Sriramareddy S, Rodriguez PC, Ruffell B, Luca VC, Tran TTT, Chen YA, and Smalley KSM. "Identification of Anti-TIM-3 Based Checkpoint Inhibitor Combinations with Activity in Immunotherapy Refractory Melanoma Models." Journal for Immunotherapy of Cancer 13, no. 8 (2025). https://doi.org/10.1136/jitc-2025-012011.
MLA (9th ed.) CitationMS, Phadke, et al. "Identification of Anti-TIM-3 Based Checkpoint Inhibitor Combinations with Activity in Immunotherapy Refractory Melanoma Models." Journal for Immunotherapy of Cancer, vol. 13, no. 8, 2025, https://doi.org/10.1136/jitc-2025-012011.
